In vitro cytogenetic assays: Chromosomal aberrations and micronucleus tests

Methods in Molecular Biology

Volumn 1044, Issue , 2013, Pages 123-146

  Mosesso, Pasquale ^a   Cinelli, Serena ^b   Natarajan, Adyapalam T ^a   Palitti, Fabrizio ^a  

^a UNIVERSITY OF TUSCIA   (Italy)

^b Research Toxicology Centre   (Italy)

Author keywords

Adherent cell lines (CHO, CHL, V79); Chromosome aberration assay protocols; Chromosome aberrations; Cytogenetic tests; Micronucleus

Indexed keywords

CYTOCHALASIN B; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; MUTAGENIC AGENT; SULFOTRANSFERASE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CENTROMERE; CHO CELL; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME ARM; CHROMOSOME BANDING PATTERN; CHROMOSOME DAMAGE; CHROMOSOME INVERSION; CONTROLLED STUDY; CULTURE MEDIUM; DICENTRIC CHROMOSOME; FLUORESCENCE MICROSCOPE; IN VITRO STUDY; INTERPHASE; METABOLIC ACTIVATION; METAPHASE CHROMOSOME; MICRONUCLEUS; MICRONUCLEUS TEST; MITOSIS; NONHUMAN; OSMOLALITY; PH MEASUREMENT; PRIORITY JOURNAL; RECIPROCAL CHROMOSOME TRANSLOCATION; REPRODUCIBILITY; ROBERTSONIAN CHROMOSOME TRANSLOCATION; SISTER CHROMATID EXCHANGE; STATISTICAL ANALYSIS;

RATTUS;

EID: 84934437357     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-529-3_6     Document Type: Article

References (35)

1. Erickson RP (2010) Somatic gene mutation and human disease other than cancer: An update. Mutat Res 705:96-106
2. De Flora S, Izzotti A (2007) Mutagenesis and cardiovascular diseases: Molecular mechanisms, risk factors, and protective factors. Mutat Res 621:5-17
3. Hoeijmakers JH (2009) DNA damage, aging, and cancer. New Engl J Med 361:1475-1485
4. Frank SA (2010) Evolution in health and medicine Sackler colloquium: Somatic evolutionary genomics: Mutations during development cause highly variable genetic mosaicism with risk of cancer and neurodegeneration. Proc Natl Acad Sci USA 107:1725-1730
5. Slatter MA, Gennery AR (2010) Primary immunodeficiencies associated with DNA-repair disorders. Expert Rev Mol Med 685:146-165
6. Bender MA, Griggs HG, Bedford JS (1974) Mechanisms of chromosomal aberration production. III. Chemicals and ionising radiation. Mutat Res 23:197-212
7. Evans HJ (1961) Chromatid aberrations induced by gamma irradiation. I. The structure and frequency of chromatid interchanges in diploid and tetraploid cells of Vicia faba. Genetics 46:257-275
8. Evans HJ, Scott D (1969) The induction of chromosome aberrations by nitrogen mustard and its dependence on DNA synthesis. Proc R Soc Lond B Biol Sci 173:491-512
9. Kihlman BA (1977) 1,3,7,9-Tetramethyluric acid, a chromosome-damaging agent occurring as a natural metabolite in certain caffeine-producing plants. Mutat Res 39:297-315
10. Savage JRK (1975) Classification and relationships of induced chromosomal structural changes. J Med Genet 13:103-122
11. Pincu M, Bass D, Norman A (1984) An improved micronuclear assay in lymphocytes. Mutat Res 139:61-65
12. Fenech M, Morley AA (1985) Measurement of micronuclei in lymphocytes. Mutat Res 147:29-36
13. Degrassi F, Tanzarella C (1988) Immunofluorescent staining of kinetochores in micronuclei: A new assay for the detection of aneuploidy. Mutat Res 203:339-345
14. Thomson EJ, Perry PE (1988) The identification of micronucleated chromosomes: A possible assay for aneuploidy. Mutagenesis 3:415-418
15. Eastmond DA, Tucker JD (1989) Identification of aneuploidy-inducing agents using cytokinesis-blocked human lymphocytes and an anti-kinetochore antibody. Environ Mol Mutagen 13:34-43
16. Eastmond DA, Pinkel D (1990) Detection of aneuploidy-inducing agents in human lymphocytes using fluorescence in situ hibridization with chromosome specific DNA probes. Mutat Res 234:303-318
17. Marshall RR, Murphy M, Kirkland DJ et al (1996) Fluorescence in situ hybridisation (FISH) with chromosome-specific centromeric probes: A sensitive method to detect aneuploidy. Mutat Res 372:233-245
18. Natarajan AT, Tates AD, van Buul PPV et al (1976) Cytogenetic effects of mutagens/ carcinogens after activation in a microsomal system in vitro. Mutat Res 37:83-90
19. Kao FT, Puck TT (1968) Genetics of somatic mammalian cells, VII. Induction and isolation of nutritional mutants in Chinese hamster cells. Proc Natl Acad Sci USA 60:1275-1281
20. Ford DK, Yerganian G (1958) Observations on the chromosomes of Chinese hamster cells in tissue culture. J Natl Cancer Inst 21: 393-425
21. Koyama H et al (1970) A new cell line derived from newborn Chinese hamster lung tissue. Gann 61:161-167
22. Xiao Y, Natarajan AT (1998) Development of arm-specific and subtelomeric region-specific painting probes for Chinese hamster chromosomes and their utility in chromosome identification of Chinese hamster cell lines. Cytogenet Cell Genet 83:8-13
23. Matsushima T, Sawamura M, Hara K et al (1976) A safe substitute for polychlorinated biphenyls as an inducer of metabolic activation system. In: De Serres FJ, Fouts JR, Bend JR, Philpot RM (eds) In vitro metabolic activation in mutagenesis testing. Elsevier/North-Holland, Amsterdam, pp 85-88
24. Elliot BM, Combes RD, Elcombe CR et al (1992) Report of the UK Environmental Mutagen Society working party. Alternatives to Aroclor 1254-induced S9 in in vitro genotoxicity assays. Mutagenesis 7:175-177
25. Halliwell B (2003) Oxidative stress in cell culture: An under-Appreciated problem? FEBS Lett 540:3-6
26. Wee LM, Long LH, Whiteman M et al (2003) Factors affecting the ascorbate-And phenolic-dependent generation of hydrogen peroxide in Dulbecco's modified Eagles medium. Free Radic Res 37:1123-1130
27. Long LH, Kirkland D, Whitwell J et al (2007) Different cytotoxic and clastogenic effects of epigallocatechin gallate in various cell-culture media due to variable rates of its oxidation in the culture medium. Mutat Res 634:177-183
28. Santoro A, Lioi MB, Monfregola J et al (2005) l-Carnitine protects mammalian cells from chromosome aberrations but not from inhibition of cell proliferation induced by hydrogen peroxide. Mutat Res 587:16-25
29. Parry JM, Parry E, Phrakonkham P et al (2010) Analysis of published data for top concentration considerations in mammalian genotoxicity testing. Mutagenesis 25:531-538
30. Galloway SM, Lorge E, Aardema MJ et al (2011) Workshop summary: Top concentration for in vitro mammalian cell genotoxicity assays; and report from working group on toxicity measures and top concentration for in vitro cytogenetics assays (chromosome aberrations and micronucleus). Mutat Res 723: 77-83
31. Brusick D (1987) Genotoxicity produced in cultured mammalian cell assays by treatment conditions. Mutat Res 189:1-80
32. Scott D, Galloway SM, Marshall RR et al (1991) International Commission for Protection Against Environmental Mutagens and Carcinogens. Genotoxicity under extreme culture conditions: A report from ICPEMC Task Group 9. Mutat Res 257:147-205
33. Seeberg AH, Mosesso P, Forster R (1988) High-dose-level effects in mutagenicity assays utilizing mammalian cells in culture. Mutagenesis 3:213-218
34. Kirkland D, Pfuhler S, Tweats D et al (2007) How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM workshop. Mutat Res 628:31-55
35. Hayashi M, Dearfield K, Kasper P et al (2011) Compilation and use of genetic toxicity historical control data. Mutat Res 723:87-90